Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Equipe Genetique des Anomalies du Developpement, |
RCV000656419 | SCV000778429 | likely pathogenic | Epileptic encephalopathy | 2017-06-01 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001726297 | SCV001961095 | pathogenic | not provided | 2025-01-01 | criteria provided, single submitter | clinical testing | TRIT1: PVS1, PM2 |
DASA | RCV001824154 | SCV002073740 | likely pathogenic | TRIT1 Deficiency | 2022-02-05 | criteria provided, single submitter | clinical testing | The c.334del;p.(Arg112Glufs*36) is a null frameshift variant (NMD) in the TRIT1 gene and predicts alteration of the nonsense-mediate decay - NMD is present in a relevant exon to the transcript - PVS1. The variant is present at low allele frequencies population databases (rs536000212– gnomAD 0.003353%; ABraOM 0.001281 frequency - http://abraom.ib.usp.br/) -PM2_supporting. In summary, the currently available evidence indicates that the variant is likely pathogenic. |
Laboratorio de Genetica e Diagnostico Molecular, |
RCV002252196 | SCV002523621 | pathogenic | See cases | 2020-04-02 | criteria provided, single submitter | clinical testing | ACMG classification criteria: PVS1, PS4, PM2, PM3 |
Labcorp Genetics |
RCV001726297 | SCV005730396 | pathogenic | not provided | 2024-12-04 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg112Glufs*36) in the TRIT1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TRIT1 are known to be pathogenic (PMID: 24901367, 28185376). This variant is present in population databases (rs536000212, gnomAD 0.07%). This premature translational stop signal has been observed in individual(s) with epilepsy (PMID: 30977854). ClinVar contains an entry for this variant (Variation ID: 545453). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. |
OMIM | RCV003493700 | SCV004244334 | pathogenic | Combined oxidative phosphorylation deficiency 35 | 2024-02-05 | no assertion criteria provided | literature only |